126 related articles for article (PubMed ID: 36041694)
1. Prediction of endometrial cancer recurrence by using a novel machine learning algorithm: An Israeli gynecologic oncology group study.
Houri O; Gil Y; Gemer O; Helpman L; Vaknin Z; Lavie O; Arie AB; Amit A; Levy T; Namazov A; Shachar IB; Atlas I; Bruchim I; Eitan R
J Gynecol Obstet Hum Reprod; 2022 Nov; 51(9):102466. PubMed ID: 36041694
[TBL] [Abstract][Full Text] [Related]
2. Outcomes and relapse patterns of stage IB grade 2 or 3 endometrial cancer treated with adjuvant vaginal brachytherapy.
Hochreiter A; Kelly JR; Young MR; Litkouhi B; Black JD; Stromberger C; Higgins S; Schwartz PE; Damast S
Int J Gynecol Cancer; 2020 Jan; 30(1):48-55. PubMed ID: 31722964
[TBL] [Abstract][Full Text] [Related]
3. Impact of adjuvant treatment on outcome in high-risk early-stage endometrial cancer: a retrospective three-center study.
Helpman L; Perri T; Lavee N; Hag-Yahia N; Chariski HA; Kalfon S; Derazne E; Beiner ME; Kadan Y; Fishman A; Korach J; Covens A; Gien L
Int J Gynecol Cancer; 2019 Jan; 29(1):133-139. PubMed ID: 30640695
[TBL] [Abstract][Full Text] [Related]
4. Influence of body mass index on clinicopathologic features, surgical morbidity and outcome in patients with endometrial cancer.
Akbayır O; Corbacıoglu Esmer A; Numanoglu C; Cılesız Goksedef BP; Akca A; Bakır LV; Kuru O
Arch Gynecol Obstet; 2012 Nov; 286(5):1269-76. PubMed ID: 22729137
[TBL] [Abstract][Full Text] [Related]
5. Ultrastaging of 'negative' pelvic lymph nodes in patients with low- and intermediate-risk endometrioid endometrial cancer who developed non-vaginal recurrences.
Gill SE; Garzon S; Multinu F; Hokenstad AN; Casarin J; Cappuccio S; McGree ME; Weaver AL; Cliby WA; Keeney GL; Mariani A
Int J Gynecol Cancer; 2021 Dec; 31(12):1541-1548. PubMed ID: 34706876
[TBL] [Abstract][Full Text] [Related]
6. A novel prediction method for lymph node involvement in endometrial cancer: machine learning.
Günakan E; Atan S; Haberal AN; Küçükyıldız İA; Gökçe E; Ayhan A
Int J Gynecol Cancer; 2019 Feb; 29(2):320-324. PubMed ID: 30718313
[TBL] [Abstract][Full Text] [Related]
7. Lymphovascular space invasion is highly associated with lymph node metastasis and recurrence in endometrial cancer.
Hahn HS; Lee IH; Kim TJ; Lee KH; Shim JU; Kim JW; Lim KT
Aust N Z J Obstet Gynaecol; 2013 Jun; 53(3):293-7. PubMed ID: 23600915
[TBL] [Abstract][Full Text] [Related]
8. Is Surgical Staging Necessary for Patients with Low-risk Endometrial Cancer? A Retrospective Clinical Analysis.
Kokcu A; Kurtoglu E; Celik H; Kefeli M; Tosun M; Onal M
Asian Pac J Cancer Prev; 2015; 16(13):5331-5. PubMed ID: 26225674
[TBL] [Abstract][Full Text] [Related]
9. The diagnosis of endometrial cancer in women with asymptomatic endometrial polyp does not increase survival rates: an israel gynecologic oncology group study.
Namazov A; Helpman L; Eitan R; Vaknin Z; Lavie O; Ben-Arie A; Amit A; Levy T; Volodarsky M; Atlas I; Bruchim I; Gemer O
Maturitas; 2021 Jun; 148():18-23. PubMed ID: 34024347
[TBL] [Abstract][Full Text] [Related]
10. Prediction of lymphovascular space invasion in patients with endometrial cancer.
Kim SI; Yoon JH; Lee SJ; Song MJ; Kim JH; Lee HN; Jung G; Yoo JG
Int J Med Sci; 2021; 18(13):2828-2834. PubMed ID: 34220310
[No Abstract] [Full Text] [Related]
11. Factors associated with an increased risk of recurrence in patients diagnosed with high-grade endometrial cancer undergoing minimally invasive surgery: A study of the society of gynecologic oncology of Canada (GOC) community of practice (CoP).
Feigenberg T; Cormier B; Gotlieb WH; Jegatheeswaran K; Helpman L; Kim SR; Lau S; May T; Saab D; Plante M; Renaud MC; Samouelian V; Shamiya S; Vicus D; Wright K; Kwon JS
Gynecol Oncol; 2021 Sep; 162(3):606-612. PubMed ID: 34183164
[TBL] [Abstract][Full Text] [Related]
12. Lymphovascular Space Invasion Portends Poor Prognosis in Low-Risk Endometrial Cancer.
dos Reis R; Burzawa JK; Tsunoda AT; Hosaka M; Frumovitz M; Westin SN; Munsell MF; Ramirez PT
Int J Gynecol Cancer; 2015 Sep; 25(7):1292-9. PubMed ID: 26067863
[TBL] [Abstract][Full Text] [Related]
13. Nomogram with potential clinical use to predict lymph node metastasis in endometrial cancer patients diagnosed incidentally by postoperative pathological assessment.
Taşkın S; Şükür YE; Varlı B; Koyuncu K; Seval MM; Ateş C; Yüksel S; Güngör M; Ortaç F
Arch Gynecol Obstet; 2017 Oct; 296(4):803-809. PubMed ID: 28762064
[TBL] [Abstract][Full Text] [Related]
14. An Assessment of Prognostic Factors, Adjuvant Treatment, and Outcomes of Stage IA Polyp-Limited Versus Endometrium-Limited Type II Endometrial Carcinoma.
Liang LW; Perez AR; Cangemi NA; Zhou Q; Iasonos A; Abu-Rustum N; Alektiar KM; Makker V
Int J Gynecol Cancer; 2016 Mar; 26(3):497-504. PubMed ID: 26825840
[TBL] [Abstract][Full Text] [Related]
15. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
[TBL] [Abstract][Full Text] [Related]
16. [The first Mexican consensus of endometrial cancer. Grupo de Investigación en Cáncer de Ovario y Tumores Ginecológicos de México].
Ruvalcaba-Limón E; Cantú-de-León D; León-Rodríguez E; Cortés-Esteban P; Serrano-Olvera A; Morales-Vásquez F; Sosa-Sánchez R; Poveda-Velasco A; Crismatt-Zapata A; Santillán-Gómez A; Aguilar-Jiménez C; Alanís-López P; Alfaro-Ramírez P; Alvarez-Avitia MA; Aranda-Flores CE; Arias-Ceballos JH; Arrieta-Rodríguez O; Barragán-Curiel E; Botello-Hernández D; Brom-Valladares R; Cabrera-Galeana PA; Cantón-Romero JC; Capdeville-García D; Cárdenas-Sánchez J; Castorena-Roji G; Cepeda-López FR; Cervantes-Sánchez G; Cetina-Pérez Lde C; Coronel-Martínez JA; Cortés-Cárdenas SA; Cruz-López JC; de la Garza-Salazar JG; Díaz-Romero C; Dueñas-González A; Valle-Solís AE; Escudero-de los Ríos P; Flores-Alvarez E; García-Matus R; Gerson-Cwilich R; González-Enciso A; González-de-León C; Guevara-Torres AG; Herbert-Núñez GS; Hernández-Hernández C; Hernández-Hernández DM; Isla-Ortiz D; Jesús-Sandoval R; Jiménez-Cervantes C; Kuri-Exsome R; López-Obispo JL; Maffuz-Aziz A; Martínez-Barrera LM; Medina-Castro JM; Montalvo-Esquivel G; Mora-Aguilar VH; Morales-Palomares MA; Morán-Mendoza A; Morgan-Villela G; Mota-García A; Muñoz-González DE; Murillo-Cruz DA; Novoa-Vargas A; Ochoa-Carrillo FJ; Oñate-Ocaña LF; Ortega-Rojo A; Palacios-Martínez AG; Palomeque-López A; Pérez-Montiel MD; Quijano-Castro F; Rivera-Rivera S; Rivera-Rubí LM; Robles-Flores JU; Rodríguez-Trejo A; Salas-Gonzáles E; Silva JA; Solorza-Luna G; Souto-del-Bosque R; Tirado-Gómez LL; Torrescano-González S; Torres-Lobatón A; Trejo-Durán E; Villavicencio-Valencia V; Gallardo-Rincón D;
Rev Invest Clin; 2010; 62(6):583, 585-605. PubMed ID: 21416918
[TBL] [Abstract][Full Text] [Related]
17. Using machine learning to create prognostic systems for endometrial cancer.
Praiss AM; Huang Y; St Clair CM; Tergas AI; Melamed A; Khoury-Collado F; Hou JY; Hu J; Hur C; Hershman DL; Wright JD
Gynecol Oncol; 2020 Dec; 159(3):744-750. PubMed ID: 33019982
[TBL] [Abstract][Full Text] [Related]
18. A clue towards improving the European Society of Medical Oncology risk group classification in apparent early stage endometrial cancer? Impact of lymphovascular space invasion.
Bendifallah S; Canlorbe G; Raimond E; Hudry D; Coutant C; Graesslin O; Touboul C; Huguet F; Cortez A; Daraï E; Ballester M
Br J Cancer; 2014 May; 110(11):2640-6. PubMed ID: 24809776
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for tumor recurrence in endometrioid endometrial cancer stages IA and IB.
Han KH; Kim HS; Lee M; Chung HH; Song YS
Medicine (Baltimore); 2017 May; 96(21):e6976. PubMed ID: 28538399
[TBL] [Abstract][Full Text] [Related]
20. Early stage papillary serous or clear cell carcinoma confined to or involving an endometrial polyp: outcomes with and without adjuvant therapy.
Chang-Halpenny CN; Natarajan S; Hwang-Graziano J
Gynecol Oncol; 2013 Dec; 131(3):598-603. PubMed ID: 24135679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]